Serum M-spike and transplant outcome in patients with multiple myeloma.
about
Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma.Improving stem cell mobilization strategies: future directions.Cancer phenotype as the outcome of an evolutionary game between normal and malignant cellsMultiple mutant clones in blood rarely coexist.
P2860
Serum M-spike and transplant outcome in patients with multiple myeloma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Serum M-spike and transplant outcome in patients with multiple myeloma.
@en
Serum M-spike and transplant outcome in patients with multiple myeloma.
@nl
type
label
Serum M-spike and transplant outcome in patients with multiple myeloma.
@en
Serum M-spike and transplant outcome in patients with multiple myeloma.
@nl
prefLabel
Serum M-spike and transplant outcome in patients with multiple myeloma.
@en
Serum M-spike and transplant outcome in patients with multiple myeloma.
@nl
P2860
P50
P1433
P1476
Serum M-spike and transplant outcome in patients with multiple myeloma.
@en
P2093
Dennis A Gastineau
Shaji K Kumar
P2860
P304
P356
10.1111/J.1349-7006.2007.00499.X
P577
2007-05-04T00:00:00Z